Silgan Holdings reported higher adjusted earnings for the third quarter of 2026, while net income and reported earnings per share declined from a year earlier. The packaging company also raised the midpoint of its full-year earnings estimate and said it expects earnings and free cash flow to grow in 2027.
The results come as Silgan advances a portfolio transformation that includes its previously announced acquisition of Trivium. The earnings release described the deal as an acceleration of that transformation but did not provide transaction terms in the material provided.
Key details
- Third-quarter sales were $2.04 billion, up from $2.01 billion in the same quarter of 2025.
- Net income fell to $105.0 million from $113.3 million. Diluted earnings per share declined to 99 cents from $1.06.
- Adjusted diluted earnings per share rose to $1.31 from $1.22, a 7% increase. Silgan said the result was at the high end of its estimated range and a third-quarter record. Adjustments added 32 cents per share to this year’s net income figure, compared with 16 cents a year earlier.
- Silgan raised the midpoint of its full-year earnings estimate. The supplied release excerpt does not include the revised estimate or its prior range.
- The company reported double-digit growth in North American dispensing products for pharmaceutical markets and mid-single-digit growth in dispensing products for fragrance markets.
- Silgan said it anticipates earnings and free cash flow growth in 2027.
- The company’s portfolio plans include the acquisition of Trivium, which it characterized as a transformative step. The excerpt provides no purchase price, financing details or expected closing date.
What the results show
Adjusted earnings per share increased even as net income and reported EPS declined. The gap reflects, in part, larger per-share adjustments in the latest quarter; the excerpt does not specify the items behind those adjustments. The full-year estimate increase and 2027 growth outlook point to management’s expectations for improved earnings and cash generation, alongside the company’s portfolio repositioning.